House Appropriations Pushes FDA on Continuous Manufacturing

The House Appropriations committee approved nearly $3.3 billion in spending for the FDA for fiscal year 2020 and once again nudged the agency to get going on its delayed continuous manufacturing initiative.
Source: Drug GMP Report